2,759 results match your criteria: "Centre de recherche du CHU[Affiliation]"
Eur J Nucl Med Mol Imaging
December 2024
Department of Medical Imaging, College of Medicine, University of Saskatchewan, Saskatoon, SK, S7N 0W8, Canada.
Purpose: We report the preclinical evaluation of potent long-acting [Ac]Ac-EBTATE against SSTR2-positive small cell lung cancer (SCLC) and pancreatic neuroendocrine tumors (pan-NETs).
Methods: The pharmacokinetic, biodistribution, and safety studies were evaluated in healthy female and/or male BALB/c mice after intravenous injections of [Ac]Ac-EBTATE. Further biodistribution and radioligand therapy were investigated in female athymic BALB/c nude mice bearing high or low SSTR2-expressing subcutaneous SCLC models NCI-H524 or NCI-H727, respectively, and in a pan-NET model QGP1.
Mol Oral Microbiol
December 2024
Faculty of Dentistry, University of Toronto, Toronto, Ontario, Canada.
Streptococcus mutans, a key player in dental caries, faces multiple environmental challenges within the oral cavity, including oxidative stress, nutrient scarcity, and acidic pH. To survive and thrive, S. mutans has evolved intricate mechanisms, including the CSP-ComDE quorum sensing system, which coordinates responses to environmental cues.
View Article and Find Full Text PDFMed Image Anal
February 2025
Centre de Recherche du CHU Sainte-Justine, Montréal, QC, Canada; Polytechnique Montréal, Montréal, QC, Canada. Electronic address:
Anterior vertebral tethering (AVT) is a non-invasive spine surgery technique, treating severe spine deformations and preserving lower back mobility. However, patient positioning and surgical strategies greatly influences postoperative results. Predicting the upright geometry from pediatric spines is needed to optimize patient positioning in the operating room (OR) and improve surgical outcomes, but remains a complex task due to immature bone properties.
View Article and Find Full Text PDFAnn Intern Med
November 2024
Centre de recherche du CHU de Québec-Université Laval and Département de médecine sociale et préventive, Université Laval, Québec City, Québec, Canada, and Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom (M.B.).
Genes Dis
March 2025
Centre de recherche du CHU de Québec at the L'Hôtel-Dieu de Québec, Services de néphrologie, pathologie et cancérologie, Département de médecine, Université Laval, Québec G1R 2J6, Canada.
Brain
January 2025
Centre de Recherche du CHU de Québec, Université Laval, Axe Neurosciences, Québec G1V 4G2, QC, Canada.
This scientific commentary refers to ‘Proteostasis as a fundamental principle of Tau immunotherapy’ by Cruz (https://doi.org/10.1093/brain/awae254).
View Article and Find Full Text PDFOpen Biol
November 2024
Division of Medical Sciences, University of Victoria, Victoria, British Columbia, Canada.
Psychological stress is the major risk factor for major depressive disorder. Sustained stress causes changes in behaviour, brain connectivity and in its cells and organelles. Resilience to stress is understood as the ability to recover from stress in a positive way or the resistance to the negative effects of psychological stress.
View Article and Find Full Text PDFData Brief
December 2024
Department of Molecular Medicine, Faculty of Medicine, Université Laval, 1050 avenue de la Médecine, Québec City, Québec G1V 0A6, Canada.
Prostate cancer is a hormone-dependent disease that relies on the androgen signaling, as well as on the estrogen signaling, for growth and survival. To identify the genes regulated by these sex-steroid hormones in the human prostate cancer cell line VCaP, these cells were treated for 24 h with either androgens and/or estrogens. Then, the RNA of each sample was purified for sequencing to generate bulk mRNA-seq data.
View Article and Find Full Text PDFBrachytherapy
January 2025
Carleton Laboratory for Radiotherapy Physics, Physics Department, Carleton University, Ottawa, ON, Canada. Electronic address:
Purpose: Demonstrate quantitative characterization of 3D patient-specific absorbed dose distributions using Haralick texture analysis, and interpret measures in terms of underlying physics and radiation dosimetry.
Methods: Retrospective analysis is performed for 137 patients who underwent permanent implant prostate brachytherapy using two simulation conditions: "TG186" (realistic tissues including 0-3.8% intraprostatic calcifications; interseed attenuation) and "TG43" (water-model; no interseed attenuation).
Can J Neurol Sci
November 2024
Axe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval, Québec, Canada.
Background: Parkinson's disease (PD) chronic L-Dopa treatment often triggers motor complications, such as L-Dopa-induced dyskinesias (LID). LID are reported to be associated with abnormal glutamatergic activity between the striatum and primary motor cortex (M1), resulting in M1 hyperactivation. Beneficial noninvasive brain stimulation (NIBS) paradigms were reported to normalize glutamatergic activity.
View Article and Find Full Text PDFJ Natl Cancer Inst Monogr
November 2024
Center for Health Decision Science, Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Background: A concern in high-income countries is that switching to 1-dose human papillomavirus (HPV) vaccination could cause a rebound in HPV infection and cervical cancer if 1-dose efficacy or duration were inferior to 2 doses. Using mathematical modeling and up-to-date trial-based data, we projected the population-level effectiveness of switching from 2-dose to 1-dose vaccination under different vaccine efficacy and duration assumptions in high-income countries.
Methods: We used HPV-ADVISE (Agent-based Dynamic model for VaccInation and Screening Evaluation), a transmission-dynamic model of HPV infection and cervical cancer, varying key model assumptions to identify those with the greatest impact on projections of HPV-16 and cervical cancer incidence over time: 1) 1-dose vaccine efficacy and vaccine duration, 2) mechanisms of vaccine efficacy and duration over time, 3) midadult (>30 years of age) sexual behavior, 4) progression to cervical cancer among midadults, and 5) vaccination coverage and programs.
J Natl Cancer Inst Monogr
November 2024
Center for Health Decision Science, Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
JAMA Pediatr
January 2025
Université de Montréal, Montreal, Quebec, Canada.
Importance: Dual language learners (DLL) (ie, children learning 2 or more languages) present lower school readiness than non-DLL children, putting DLL children at risk of later school difficulties and adverse outcomes. However, it is unclear whether participation in early childhood education and care (ECEC) services may reduce this gap.
Objective: To assess whether ECEC exposure may reduce the school readiness gap between DLL and non-DLL children in a population-based sample.
Leuk Lymphoma
November 2024
Hematology/Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
Br J Clin Pharmacol
November 2024
Pharmacy Department, McGill University Health Center, Montréal, QC, Canada.
Aims: Patients undergoing haemodialysis (HD) are at greater risk of methicillin-resistant Staphylococcus aureus infections requiring intravenous vancomycin. Close vancomycin therapeutic drug monitoring is warranted in HD patients as renal clearance is the primary elimination pathway. Clinically, population pharmacokinetics (popPK) model-informed dosing is commonly used.
View Article and Find Full Text PDFChemMedChem
November 2024
Department of Chemistry, Miranda House, University of Delhi, Delhi, 110007.
In this manuscript, twenty-one novel fluorinated piperazine-hydroxyethylamine analogues were synthesized and tested against Plasmodium falciparum (Pf). Among tested compounds, two 13 g and 14 g exhibited promising inhibitory activity on Pf3D7 with IC values of 0.28 and 0.
View Article and Find Full Text PDFBrain Behav
November 2024
School of public health, University of Montreal, Montreal, Quebec, Canada.
Background: Producing relevant knowledge on the prevalence of mood disorders (MDs) requires a clear identification of people living with the condition. Analyzing this multifaceted disease from the perspective of health administrative data and population-based surveys could contribute to document inconsistencies between these data sources and highlight the strengths and limitations of each methodological approaches.
Objectives: The aim of this study was to estimate the prevalence of MD disease, assess concordance of MD patterns in population-based surveys versus health administrative data, and investigate statistical differences in characteristics between individuals presenting the disease in each data sources.
Infect Control Hosp Epidemiol
November 2024
Division of Infectious Diseases, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada.
Late-onset sepsis (LOS) in the neonatal intensive care unit (NICU) causes significant morbidity and mortality, yet guidance on empiric management is limited. We surveyed NICUs across Canada and the United States regarding their empiric antimicrobial regimens for LOS, thereby identifying large practice variations and high rates of empiric vancomycin use.
View Article and Find Full Text PDFAm J Obstet Gynecol MFM
December 2024
Centre de Recherche du CHU de Québec-Université Laval, Québec, Canada (Bujold, Dubé, Girard, and Chaillet); Department of Obstetrics and Gynecology, Faculty of Medicine, Université Laval, Québec, Canada (Bujold and Chaillet).
Background: Third-trimester lower uterine segment thickness (LUST) is associated with uterine rupture during trial of labor after cesarean (TOLAC) but threshold values vary according to the approach used (lower values with vaginal ultrasound, higher values with abdominal ultrasound).
Objective: To estimate the optimal LUST cut-off value combining vaginal and abdominal ultrasound to predict uterine rupture during TOLAC.
Study Design: We performed a secondary analysis of PRISMA cluster randomized trial including women with a single previous cesarean who underwent ultrasound LUST measurement at 34-38 weeks using the thinnest measurement obtained by combining transvaginal and transabdominal measurements.
Radiol Artif Intell
January 2025
From the NeuroPoly Laboratory, Institute of Biomedical Engineering, Polytechnique Montréal, 2500 Chemin de Polytechnique, Montréal, Québec, Canada H3T 1J4 (E.N.K., J.V., J.C.A.); Mila-Quebec AI Institute, Montréal, Québec, Canada (E.N.K., J.V., J.C.A.); Department of Neurosurgery and Department of Neurology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Olomouc, Czechia (J.V.); Department of Physical Medicine and Rehabilitation Physical Therapy Program, University of Colorado School of Medicine, Aurora, Colo (A.C.S.); Spinal Cord Injury Center, Balgrist University Hospital, University of Zürich, Zürich, Switzerland (D.P., S.S.S., L.F., P.F.); Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, Calif (D.P., K.A.W.); Department of Neurophysics, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany (P.F.); and Functional Neuroimaging Unit, CRIUGM and Centre de Recherche du CHU Sainte-Justine, Université de Montréal, Montréal, Québec, Canada (J.C.A.).
JACC CardioOncol
October 2024
Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
Background: There are limited data on the physical effects of androgen deprivation therapy (ADT) for prostate cancer (PC), and on the relationships of such measures of adiposity and strength to cardiovascular outcomes.
Objectives: The primary objective of this study was to evaluate the relationships of measures of adiposity and strength to cardiovascular outcomes (cardiovascular death, myocardial infarction, stroke, heart failure, arterial revascularization, peripheral arterial disease, and venous thromboembolism) in patients with PC. A secondary objective was to characterize the relationships between ADT use and 12-month changes in these physical measures.
BMC Emerg Med
October 2024
Pôle Médecine d'Urgence - Place du Dr Joseph Baylac, CHU Toulouse, Toulouse, 31300, France.
Leukemia
January 2025
Laboratory for High Throughput Biology, Montréal, QC, Canada.
Targeted therapeutics for high-risk cancers remain an unmet medical need. Here we report the results of a large-scale screen of over 11,000 molecules for their ability to inhibit the survival and growth in vitro of human leukemic cells from multiple sources including patient samples, de novo generated human leukemia models, and established human leukemic cell lines. The responses of cells from de novo models were most similar to those of patient samples, both of which showed striking differences from the cell-line responses.
View Article and Find Full Text PDFJAMA Netw Open
October 2024
Department of Social and Preventive Medicine, School of Medicine, Laval University, Québec City, Québec, Canada.